Engflag

Acetamide

Quick links to important sections

Acetamide

Acetamide_EN

Method of action: Decongestant, Diuretic, Ophthalmologicals

Treatment option: Glaucoma, Dehydration, Seizure, Surgery, Epilepsy

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Acetamide

What is Acetazolamide?

Acetazolamide is a pharmacological agent classified as a carbonic anhydrase inhibitor. Unlike many other diuretics, it works through a specific enzymatic pathway rather than by simply altering salt balance in the kidneys. It is a synthetic derivative of sulfonamides, though it functions differently than sulfonamide-based antibiotics.

Mechanism of Action

The primary function of acetazolamide is to block the activity of carbonic anhydrase, an enzyme found in various tissues throughout the body, including the eyes, kidneys, and central nervous system.

This enzyme is responsible for the rapid conversion of carbon dioxide and water into bicarbonate and hydrogen ions. By inhibiting this process, the medication achieves several physiological effects:

  • In the Kidneys: It promotes the excretion of bicarbonate, sodium, and potassium, which leads to increased urine output and a shift in the body's acid-base balance toward a more acidic state (metabolic acidosis).
  • In the Eyes: It reduces the rate of aqueous humor formation, which helps to lower pressure within the eye.
  • In the Central Nervous System: It can reduce the abnormal discharge of neurons and decrease the production of cerebrospinal fluid.

Clinical Applications

Acetazolamide is utilized across several different medical fields due to its diverse effects on fluid dynamics and blood chemistry. Its use cases generally fall into the following categories:

1. Ophthalmology

It is frequently used to manage conditions characterized by elevated intraocular pressure. By reducing fluid production inside the eye, it helps maintain pressure levels that are less likely to damage the optic nerve.

2. Altitude Medicine

Acetazolamide is a standard option for addressing issues related to rapid ascent to high altitudes. The metabolic acidosis it induces acts as a respiratory stimulant, encouraging the body to breathe more deeply and frequently, which improves oxygenation in low-oxygen environments.

3. Neurology

Due to its effect on cerebrospinal fluid and neuronal activity, it is sometimes employed in the management of specific types of seizure disorders or conditions involving increased pressure around the brain, such as idiopathic intracranial hypertension.

4. Edema

While less common than other diuretics, it may be used to treat fluid retention (edema) associated with congestive heart failure or certain medication-induced fluid imbalances.

Regulatory References

  1. WHO Essential Medicines List

What side effects are possible with Acetamide?

Possible Side Effects and Safety Information: Acetazolamide

This information reflects the documented adverse reactions and safety statements for Acetazolamide, as defined by official government regulatory agencies.

Frequency-Classified Adverse Reactions

Adverse reactions are classified by frequency as documented in regulatory data:

  • Very Common: Paresthesia (a tingling or 'pins and needles' sensation, especially in the extremities).
  • Common: Headache, fatigue, malaise, polyuria (increased urination), and taste alterations (e.g., metallic taste).

Serious and Clinically Significant Adverse Reactions

The label documents rare but potentially life-threatening adverse reactions, which are based on Acetazolamide's mechanism as a sulfonamide derivative:

  • Severe Cutaneous Adverse Reactions (SCARs): Including Stevens-Johnson syndrome (SJS) and Toxic Epidermal Necrolysis (TEN).
  • Fatal Blood Dyscrasias: Including aplastic anemia, agranulocytosis, and thrombocytopenia.
  • Hepatotoxicity: Including fulminant hepatic necrosis.
  • Metabolic Risks: Severe metabolic acidosis and electrolyte imbalance.

Safety Restrictions and Population-Specific Cautions

Official prescribing information defines specific safety limitations for the use of Acetazolamide:

  • Contraindications: The drug is strictly limited in patients with Na^+ or K^+ depletion, hyperchloremic acidosis, and severe hepatic impairment (due to the risk of hepatic encephalopathy).
  • Pregnancy: It is officially restricted in the first trimester of pregnancy due to findings of teratogenicity in animal studies.
  • Monitoring: Periodic monitoring of serum electrolytes and complete blood counts (CBC) is required to detect early signs of blood dyscrasias and chemical imbalance.

Overdose and Emergency Response

Overdose Manifestations and Severe Outcomes

Overdosage with Acetazolamide is officially documented as leading to a state of severe metabolic acidosis and critical disturbances in electrolyte balance, specifically involving low potassium (Hypokalemia) and low sodium (Hyponatremia). Clinical manifestations documented in regulatory sources include central nervous system effects such as Lethargy, Drowsiness, and Confusion, along with Tachypnea (rapid breathing).

Severe and potentially life-threatening outcomes are possible, including Coma and Death, particularly when the medication is taken in conjunction with high-dose salicylates (aspirin). Patients who are elderly or have advanced renal impairment are also noted to be at higher risk for severe toxicity.

Required Emergency Actions

Official regulatory guidance requires that if an overdosage is suspected, individuals must contact a poison control center or emergency room at once.

No specific antidote is known for Acetazolamide. Therefore, management is symptomatic and supportive, focusing on the immediate correction of fluid and electrolyte imbalance. Due to the drug’s physical properties, the official label notes that Hemodialysis may be a particularly helpful supportive measure in managing severe cases.

Therapeutic Uses of Acetamide

Quick Facts

  • May be used to manage increased fluid pressure in the eye (glaucoma).
  • Can assist with the management of fluid retention (edema) linked to congestive heart failure or certain medications.
  • May be used alongside other treatments to help control specific types of seizures (epilepsy).
  • Used for the prevention or reduction of symptoms associated with acute mountain sickness (altitude sickness).

Acetazolamide is a prescription medication utilized in therapeutic domains to manage several conditions. A primary application is in the care of glaucoma, where it acts to reduce pressure within the eye, helping to sustain vision. The medication may also be an element of a comprehensive treatment plan for various forms of seizures, serving as an adjunct to established anticonvulsant treatments.

Furthermore, Acetazolamide is indicated for the management of edema, or fluid retention, particularly when associated with congestive heart failure or as a response to certain other medications. By supporting the body's fluid balance, it helps resolve unwanted swelling. For individuals undertaking rapid ascent, this agent is also indicated for the prevention and timely amelioration of symptoms related to acute mountain sickness.

Eligibility and Restrictions for Use

Who Can and Cannot Use Acetazolamide?

Eligibility for Acetazolamide is defined by regulatory documents, which establish absolute exclusions (contraindications) and necessary restrictions based on a patient's underlying health status and physiological condition.

Contraindicated Populations

Use is contraindicated in patients with a known hypersensitivity to sulfonamide derivatives, as Acetazolamide is a member of this chemical class. Absolute non-eligibility is also defined for those with marked hepatic impairment or failure (risk of hepatic coma) and severe renal dysfunction . Furthermore, the medication must not be used in individuals with adrenocortical insufficiency or marked imbalances in serum sodium or potassium levels.

Population Restrictions

Population Regulatory Status
Pregnancy Restricted (Pregnancy Category C); not recommended unless potential benefit justifies risk.
Lactation Restricted; Acetazolamide is excreted into breast milk.
Older Adults Use with Caution; specific monitoring is often required due to age-related changes in organ function.
Pediatric Safety and effectiveness not established by some agencies; use is conditional for specific labeled indications (e.g., epilepsy).

Long-term use is contraindicated in chronic non-congestive angle-closure glaucoma.

What should I know about interactions with other medicines?

Interactions with other medicines and products

This section summarizes documented drug-drug and drug-product interactions for Acetazolamide, as described in authoritative regulatory information.

Documented Interacting Agents

Official labeling identifies potential interactions with several categories of agents, including:

  • Salicylates (e.g., High-dose Aspirin): Concomitant use with high-dose aspirin is a noted restriction, as it may lead to severe toxicity, including metabolic acidosis, coma, and death. Caution is advised for this combination.
  • Anticonvulsants: Acetazolamide interacts with drugs such as Phenytoin and Primidone. It may increase serum levels of phenytoin by modifying its metabolism, and it may decrease serum levels of primidone by affecting its absorption. Close monitoring is necessary when starting or stopping Acetazolamide in patients on these therapies.
  • Other Carbonic Anhydrase Inhibitors: Concomitant use with other carbonic anhydrase inhibitors is generally not advisable due to the risk of additive systemic effects.
  • Lithium: Acetazolamide increases the renal excretion of Lithium, which can lead to decreased serum lithium levels.
  • Sympathomimetics: Acetazolamide reduces the urinary excretion of basic drugs like Amphetamine and Quinidine, potentially enhancing the magnitude and duration of their effects.
  • Cyclosporine: There is a documented risk of elevated serum Cyclosporine levels when co-administered with Acetazolamide.

Interaction Constraints

The interaction profile requires caution and monitoring for changes in therapeutic effects or adverse reactions. The main mechanism involves the alteration of urinary pH by Acetazolamide, which affects the excretion of other drugs. Additionally, additive effects or changes in drug metabolism necessitate careful management of these specific combinations.

Mechanism of Action

The mechanism of Acetazolamide is defined by the reversible inhibition of the enzyme Carbonic Anhydrase (CA), a metalloenzyme found in tissues including the kidney, eye, and central nervous system. This action blocks the rapid conversion of carbon dioxide ( CO2) and water ( H2 O) into bicarbonate ions ( HCO3^-) and hydrogen ions ( H^+). In the renal proximal tubules, the impaired production of H^+ disrupts the Na^+/ H^+ exchange mechanism. This results in the controlled increase in the excretion of sodium, bicarbonate, and water, which contributes to fluid modulation. Simultaneously, CA inhibition in the ciliary body and choroid plexus limits the HCO3^--driven active transport necessary for the secretion of aqueous humor and cerebrospinal fluid (CSF). The systemic loss of bicarbonate induces metabolic acidosis, which serves as a powerful stimulus to the brain's respiratory centers. This predictable consequence leads to a compensatory increase in minute ventilation (deeper, faster breathing), which modulates the body's CO2 and O2 balance. The initial physiological effect on fluid excretion is self-limiting due to the eventual depletion of plasma bicarbonate.

Dosage and Administration Information

How to Use Acetazolamide: Administration Guidelines

Acetazolamide is a medication with specific administration instructions.

Dosage Forms and Routes

Acetazolamide is available in several forms, each dictating a specific administration route:

  • Oral: Immediate-release tablets (e.g., 125 mg and 250 mg) and 500 mg extended-release capsules.
  • Intravenous (IV): Powder for injection (500 mg vial), primarily for rapid effect. The intravenous route is generally preferred over the intramuscular route.

General Dosing and Timing

Dosing is dependent on the condition being addressed, ranging from 250 mg up to 1 g total daily dose, administered either in divided doses or as a single daily dose for the extended-release form. The medication may be taken with or without food.

Administration Condition Instruction
Extended-Release Capsules must be swallowed whole; they should not be crushed or chewed.
Diuretic Schedule For managing edema, the drug is often prescribed on an intermittent basis (e.g., alternating days or two days on, one day off) and is typically taken in the morning.
IV Preparation The sterile powder must be reconstituted with a specified volume of Sterile Water for Injection before administration.
Renal Impairment Dosage may require reduction or the interval between doses may be increased for patients with decreased kidney function.

Age-Specific Use

Pediatric dosing is based on body weight, with specific limits for daily totals (e.g., up to 750 mg/day for epilepsy). The extended-release capsules are generally reserved for individuals 12 years of age and older.

Procedural Protocol

For the injectable form, the reconstituted solution must be used promptly and any unused portion stored under refrigeration must be discarded within 24 hours. The instructions require adherence to the prescribed frequency, which may be daily or cyclical, ensuring dose adjustment for known physiological factors like renal status.

Recent Clinical Evidence

Evidence for use in Reducing Elevated Eye Pressure (Glaucoma)

This section will summarize the types of clinical studies that have investigated how Acetazolamide was studied for conditions involving high fluid pressure inside the eye, including summaries of trials where it was studied alongside other evaluated options.

Research has explored the use of Acetazolamide in conditions associated with high internal eye pressure. Studies focusing on this use often monitor outcomes related to systemic or functional imbalance, such as changes in pressure measured inside the eye. Findings describe patterns observed in the studies, where research explored outcomes related to temporary changes in eye pressure in the observed populations.

Evidence for use in Preventing and Treating Altitude Sickness

This section will outline the research and clinical trial data on using Acetazolamide was evaluated in research exploring high-altitude environments, focusing on studies of prevention and treatment of Acute Mountain Sickness (AMS).

Studies explored how symptoms evolved in the observed populations, and findings indicate that Acetazolamide was associated with different patterns in the occurrence and intensity of outcomes related to physical discomfort often linked to altitude sickness. Nevertheless, results apply only to the specific ascent profiles and populations studied, and long-term effects are not fully established.

Evidence for use in Specific Seizure Disorders and Fluid Imbalances

This section will present an overview of the existing research on Acetazolamide was studied in research exploring certain types of epilepsy and in conditions involving fluid retention (edema) where it was evaluated in conditions involving fluid retention. Studies monitored outcomes reflecting daily functioning or activity level, with findings indicating an association with changes in fluid balance when the medicine was evaluated.

What is still uncertain about Acetazolamide

The overall evidence landscape for Acetazolamide, while established for its main uses, still has several gaps. Findings were mixed when comparing results to other options in some long-term scenarios. Data are still emerging for certain uses, and the certainty remains low in some areas due to modest sample sizes and limited follow-up durations. More research is needed to provide clearer insight into short-term changes and overall symptom patterns across all indications.

Frequently Asked Questions (FAQ)

Common questions about Acetazolamide (FAQ)

Q: What happens if I miss a dose of my Acetazolamide tablet?

Official product information commonly states that if a dose is missed, it should be taken as soon as it is remembered. However, if it is nearly time for the next scheduled dose, the regulatory guidance is often to skip the missed dose and continue with the regular schedule. The labeling explicitly specifies that double doses should not be taken to compensate for a missed dose.

Q: How soon after starting the drug should I expect to see an improvement in my glaucoma?

Regulatory documents indicate the drug's mechanism of action begins within 1 to 1.5 hours of administration for the immediate-release tablet, reaching its peak activity in 2 to 4 hours. The duration of this action is typically 8 to 12 hours. The extended-release capsule formulation begins its action in about 2 hours and maintains its effect for 18 to 24 hours.

Q: Is it okay to crush the regular tablets (not extended-release) and mix them with food or a liquid?

Official administration instructions documented in the labeling state that the immediate-release tablets can be crushed when a liquid dosage form is necessary for patients who cannot swallow the whole tablet. The crushed medicine can then be suspended in a liquid. It is critical to note that this procedure is specific to the immediate-release tablets, as the extended-release capsules must always be swallowed whole.

Q: What is the maximum daily dose for Acetazolamide?

The total daily dose for the treatment of various indications, including glaucoma and epilepsy, generally ranges up to 1 gram (1 g) per 24 hours. The label specifies that the total daily dose should generally not exceed this amount, as higher doses may not offer additional clinical effect.

Q: What are the symptoms of the most common side effect?

The most common adverse reaction noted in official regulatory documents is paresthesia. This condition is described as a tingling or 'pins and needles' feeling. Paresthesia is most frequently reported in the extremities, such as the hands and feet.

Q: What are the most dangerous/life-threatening side effects I need to watch out for?

Regulatory warnings highlight several serious and potentially life-threatening side effects. These include severe skin reactions, such as Stevens-Johnson syndrome, and fatal blood disorders, including aplastic anemia. Other serious risks are severe liver damage and metabolic acidosis with electrolyte imbalance.

How should Acetamide be stored and disposed of?

How to Store and Dispose of Acetazolamide?

The storage and disposal of Acetazolamide must adhere strictly to official regulatory guidelines to maintain product integrity and safety.

Storage Conditions

Oral forms (tablets and capsules) should be stored at Controlled Room Temperature (20 C to 25 C), protected from moisture and direct light. The product must be kept in its original closed container and not be frozen.

For the sterile powder, the solution reconstituted for injection requires stability-linked storage: 3 days if refrigerated (2 C to 8 C), or 12 hours at room temperature. Any unused portion must be discarded after these time limits, as the solution contains no preservative.

Disposal and Safety

It is mandatory to keep this medication out of the sight and reach of children and pets. Disposal of unused or expired medicine must follow local regulations. The recommended method is often a community drug take-back program. If using household trash, the medicine must be removed from its container, mixed with an undesirable substance, and sealed before disposal.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

flagIndia

Equivalent of Acetamide found in:

A-Z Index: